FIGURE 1.
Distribution of oncogenic driver alterations detected by the Amoy 9‐in‐1 assay (a) and the next‐generation sequencing (NGS) assays (b) in patients with non‐small cell lung cancer.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.